Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 23, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - June 23, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

6/23/17 - 22nd Century Receives Guidance from FDA on Phase III Clinical Trials [Tehran Times (Iran)]
22nd Century Group, Inc., a plant biotechnology company that is a leader in tobacco harm reduction, announced today that on June 20, 2017, the Company and its wholly owned subsidiary, Heracles Pharmaceuticals, participated in a meeting with the multi-discipline review team in the Division of Anesthesia, Analgesia, and Addiction Products at the Cent
6/23/17 - Abbott Laboratories' Trademark Application for "PRO SCIENCE PUSH" Filed
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "PRO SCIENCE PUSH" by Cheryl A. Withycombe, representing Abbott Laboratories. The owner/registrar information for this application is: Cheryl A. Withycombe, A
6/23/17 - AbbVie Announces Pivotal Phase 2 Trial Evaluating VENCLYXTO? (venetoclax) in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) with 17p Deletion to be Presented at 22nd European Hematology Association (EHA) Annual Congress
AbbVie, a global biopharmaceutical company, today announced the presentation of results from the pivotal Phase 2 study of VENCLYXTO?, a first-in-class oral B-cell lymphoma-2 inhibitor. VENCLYXTO monotherapy was granted conditional marketing authorization in the EU for the treatment of CLL in the presence of 17 p deletion or TP53 mutation in adu
6/23/17 - Advanced Infusion Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 20162024
The key factors that are driving the advanced infusion systems market are the overall growth in the global population that are suffering from diabetes, cancer, and chronic disease.Sarasota, FL 06/22/2017 Zion Market Research, the market research group announced the analysis report titled " Advanced Infusion Systems Market: Global Industry Ana
6/23/17 - Akari Therapeutics to Present Data from Phase 2 PNH Trial of Coversin at the 22nd Congress of the European Hematology Association
Akari Therapeutics, a clinical-stage biopharmaceutical company, is presenting a poster today at the 22nd Congress of the European Hematology Association in Madrid, Spain containing data for the four patients, to date, who have completed its ongoing Phase 2 trial of Coversin in paroxysmal nocturnal hemoglobinuria. Coversin is a second-generation..
6/23/17 - Alexion Receives Positive CHMP Opinion for Soliris (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG) in the European Union
Alexion Pharmaceuticals, Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion to extend the current therapeutic indication for Soliris to include the treatment of refractory generalized myasthenia gravis in patients who are anti-acetylcholine receptor...
6/23/17 - Allantoin Market Is Expected To Witness Growth Swiftly Based On Rising Demand From Various Application Such As Cosmetics And Pharmaceutical Till 2022: Grand View Research, Inc
According to report published by Grand View Research, Global Allantoin Market is expected to reach USD 641.7 million by 2022. Growing application scope of allantoin in pharmaceutical industry is anticipated to drive market growth over the forecast period. Global Allantoin Market is expected to reach USD 641.7 million by 2022, according to a new stu
6/23/17 - Amgen Receives Positive CHMP Opinion To Expand Use Of Mimpara (cinacalcet) For The Treatment Of Secondary Hyperparathyroidism In Certain Children With End-Stage Renal Disease On Dialysis
THOUSAND OAKS, Calif., June 23, 2017/ PRNewswire/ Amgen today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for the Marketing Authorization of a pediatric formulation of Mimpara . The CHMP positive opinion will now be reviewed by the European Commission, which h
6/23/17 - An Application for the Trademark "ENSURE HEALTHY MATTERS" Has Been Filed by Abbott Laboratories
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "ENSURE HEALTHY MATTERS" by Elisa M. Valenzona, representing Abbott Laboratories. The owner/registrar information for this application is: Elisa M. Valenzona,
6/23/17 - An Application for the Trademark "PRO SCIENCE FINISH" Has Been Filed by Abbott Laboratories
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "PRO SCIENCE FINISH" by Cheryl A. Withycombe, representing Abbott Laboratories. The owner/registrar information for this application is: Cheryl A. Withycombe,
6/23/17 - Another View Drug importation would worsen the opioid crisis
Bernie Sanders is sponsoring a bill that would allow people to import packages of prescription drugs from Canada. Maggie Hassan, New Jersey Sen. Cory Booker, and Minnesota Sen. Al Franken also support the bill.
6/23/17 - Arbutus Biopharma Corp. Files SEC Form 8-K, Current Report (Jun. 2, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Arbutus Biopharma Corp. was posted on June 2, 2017. The SEC file number is 0001171843-17-003427.. A U.S. Securities and Exchange Commission filing is a formal d
6/23/17 - As White House Prepares Gift to Big Pharma, Sen. Franken and Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down Prescription...
Franken and Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down Prescription Drug Costs. Franken and Lawmakers Press President Trump to Get Behind Real Solutions to Bring Down Prescription Drug Costs. WASHINGTON, D.C. As the White House prepares to gift the big pharmaceutical companies with an executive order that reportedl
6/23/17 - Astellas president wants people to focus on lives saved by pharmaceutical industry [Chicago Tribune]
June 22 Jim Robinson just wrapped up his first year as president of Astellas Americas and it was quite a year for the pharmaceutical industry. Robinson, 47, is based in Northbrook, where he heads North and South American operations for Japanese drugmaker Astellas Pharma. A: Mark Kaufman and Mary Ann Kaufman, his wife, are responsible for me bei
6/23/17 - AVEO Oncology Announces Positive CHMP Opinion for Tivozanib as a Treatment of Advanced Renal Cell Carcinoma
AVEO Oncology today announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has recommended FOTIVDA? for approval as a treatment for patients with advanced renal cell carcinoma. The CHMP's recommendation is now referred to the European Commission. Mr. Bailey concluded: If th
6/23/17 - BARDA Gives Notice of Intent to Exercise First Contract Option to Further Fund MediWound's NexoBrid Development
MediWound Ltd., a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn and wound management, announces that it received from the U.S. Biomedical Advanced Research and Development Authority a written Notice of Intent to exercise an option to fund further research and development...
6/23/17 - Bellicum Announces Clinical Data on BPX-501 at Presidential Symposium of the 22nd Congress of the European Hematology Association
Bellicum Pharmaceuticals, Inc., a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, announced that results will be presented today from its global BP-004 clinical trial of BPX-501 in the Presidential Symposium at the 22 nd Congress of the European Hematology Association being held
6/23/17 - Benitec Biopharma Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16] (Jun. 2, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Benitec Biopharma Ltd was posted on June 2, 2017. The SEC file number is 0001144204-17-030718.. A U.S. Securities and Exchange Commission filing is a formal doc
6/23/17 - Benitec Biopharma Ltd Files SEC Form F-3, Registration Statement By Foreign Private Issuers (Jun. 1, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Benitec Biopharma Ltd was posted on June 1, 2017. The SEC file number is 0001193125-17-190236.. A U.S. Securities and Exchange Commission filing is a formal doc
6/23/17 - Biogen's IMRALDI, an Adalimumab Biosimilar Candidate Referencing Humira, Granted Positive Opinion by Committee for Medicinal Products for Human Use
The Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for IMRALDI , an adalimumab biosimilar candidate referencing Humira . 1 The positive opinion will now be referred to the European Commission, which grants marketing authorization for medicines in the European Union. Today, the anti-
6/23/17 - Biopharmaceutical Contract Manufacturing Market (2nd Edition), 2017-2027
Dublin- Research and Markets has announced the addition of the "Biopharmaceutical Contract Manufacturing Market, 2017-2027" report to their offering. Over the years, the biopharmaceutical market has grown into a prominent and promising segment of the overall pharmaceutical industry. Characterized by a number of blockbuster therapies and a robust...
6/23/17 - Biopharmaceutical Contract Manufacturing Market (2nd Edition), 2017-2027 - Research and Markets
Research and Markets has announced the addition of the "Biopharmaceutical Contract Manufacturing Market, 2017-2027" report to their offering. Over the years, the biopharmaceutical market has grown into a prominent and promising segment of the overall pharmaceutical industry. Characterized by a number of blockbuster therapies and a robust pipeline o
6/23/17 - Biova, LLC. Brings New Board Member on for a Fresh Perspective
Dr. Henig will bring a wealth of scientific experience in the food, beverage, nutrition and dietary supplement areas. Dr. Henig has served as the Chief Technical and Scientific Officer of four major global companies in the last 4 decades. Biova's CEO, Pat Schneider, who has previously worked with Dr. Henig during her time at Herbalife, was enthusia
6/23/17 - Bipartisan Group of Members of Senate Judiciary Committee Urge FDA Commissioner to Address Abuses in Regulatory Process That Delay Competition, Increase Prescription Drug Costs
Commissioner Gottlieb recently stated that the FDA will take measures to curb anticompetitive abuses of its regulatory process for the approval of generic drugs. In their letter, the senators advocate for their legislative solution and ask Commissioner Gottlieb to detail the regulatory actions the FDA can and cannot take to address strategies that.
6/23/17 - Can-fite Biopharma Ltd. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16] (Jun. 1, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Can-fite Biopharma Ltd. was posted on June 1, 2017. The SEC file number is 0001213900-17-006037.. A U.S. Securities and Exchange Commission filing is a formal d
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415